WallStreetZenWallStreetZen

NASDAQ: INBX
Inhibrx Biosciences Inc Stock Ownership - Who owns Inhibrx Biosciences?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Inhibrx Biosciences Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Jon Faiz KayyemDirector2024-11-2018,750$14.19
$266.10kBuy
Jon Faiz KayyemDirector2024-11-2018,750$14.19
$266.10kBuy
Jon Faiz KayyemDirector2024-11-1934,843$14.23
$495.71kBuy
Jon Faiz KayyemDirector2024-11-1934,843$14.23
$495.71kBuy
Kristiina Md VuoriDirector2024-10-036,667$15.00
$100.01kBuy

1 of 1

INBX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when INBX insiders and whales buy or sell their stock.

INBX Shareholders

What type of owners hold Inhibrx Biosciences Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Viking Global Investors LP12.34%1,787,705$49.20MInstitution
Inhibrx Inc7.99%1,157,926$31.87MInsider
Sanofi7.99%1,157,926$31.87MInstitution
Jon Faiz Kayyem7.31%1,059,046$29.14MInsider
Mark Lappe7.25%1,050,413$28.91MInsider
Perceptive Advisors LLC6.75%977,892$26.91MInstitution
Hightower Advisors LLC6.02%871,759$23.99MInstitution
Blackrock Inc5.03%728,744$20.06MInstitution
Sofinnova Investments Inc4.89%708,678$19.50MInstitution
Woodline Partners LP4.58%662,868$18.24MInstitution

1 of 3

INBX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
INBX71.67%28.33%Net Buying
ABSI59.87%33.20%Net SellingNet Buying
YMAB61.42%38.58%Net Buying
FULC62.17%37.83%Net Selling
ZVRA64.43%22.19%Net SellingNet Buying
View Top Biotech Stocks

Inhibrx Biosciences Stock Ownership FAQ

Who owns Inhibrx Biosciences?

Inhibrx Biosciences (NASDAQ: INBX) is owned by 72.04% institutional shareholders, 28.47% Inhibrx Biosciences insiders, and 0.00% retail investors. Inhibrx Inc is the largest individual Inhibrx Biosciences shareholder, owning 1.16M shares representing 7.99% of the company. Inhibrx Inc's Inhibrx Biosciences shares are currently valued at $31.48M.

If you're new to stock investing, here's how to buy Inhibrx Biosciences stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.